IN RE: Proton-Pump Inhibitor Products Liability Litigation (No. II) (MDL No. 2789)
MDL No. 2789 had 11,404 actions pending in the D. New Jersey before Judge Claire C. Cecchi on .
A multidistrict litigation (MDL) is a group of suits the Judicial Panel on Multidistrict Litigation (JPML) sends to one judge for pretrial work (more).
Data through , from the panel's pending MDL report.
On the newest report
The transferee court is the district whose judge runs the MDL.
| MDL number | 2789 |
|---|---|
| Litigation | IN RE: Proton-Pump Inhibitor Products Liability Litigation (No. II) |
| Transferee court | District Court, D. New Jersey |
| Judge | Claire C. Cecchi (U.S. District Judge) |
| Actions pending | 11,404 on |
| Actions in all | 18,755 filed in this MDL since it began |
| Since the report before | no change (from 11,404 on ) |
| First report listing it |
Source: jpml.uscourts.gov, jpml.uscourts.gov.
Actions pending, report by report
Actions pending are the lawsuits in this MDL that have not yet ended; the panel reports the count once a month.
solid = printed in that month's report
| Report | Actions pending | Actions in all | Change | Source |
|---|---|---|---|---|
| 11,404 | 18,755 | no change | JPML report | |
| 11,404 | 18,755 | no change | JPML report | |
| 11,404 | 18,755 | +83 | JPML report | |
| 11,321 | 18,706 | no change | JPML report | |
| 11,321 | 18,706 | no change | JPML report | |
| 11,321 | 18,706 | -1 | JPML report | |
| 11,322 | 18,706 | no change | JPML report | |
| 11,322 | 18,706 | no change | JPML report | |
| 11,322 | 18,706 | no change | JPML report | |
| 11,322 | 18,706 | no change | JPML report | |
| 11,322 | 18,706 | -6 | JPML report | |
| 11,328 | 18,706 | -3 | JPML report | |
| 11,331 | 18,706 | no change | JPML report | |
| 11,331 | 18,706 | -5 | JPML report | |
| 11,336 | 18,706 | -52 | JPML report | |
| 11,388 | 18,706 | -203 | JPML report | |
| 11,591 | 18,706 | -86 | JPML report | |
| 11,677 | 18,706 | -51 | JPML report | |
| 11,728 | 18,706 | -80 | JPML report | |
| 11,808 | 18,706 | -143 | JPML report | |
| 11,951 | 18,706 | -23 | JPML report | |
| 11,974 | 18,706 | -1 | JPML report | |
| 11,975 | 18,706 | no change | JPML report | |
| 11,975 | 18,706 | -1 | JPML report | |
| 11,976 | 18,706 | first report | JPML report |
MDL and member dockets
The MDL's own docket is its master case; member dockets are the individual cases moved into it.
- 2:17-md-02789 in the D. New Jersey, the MDL docket, opened
Other MDLs before this court
These MDLs are run by judges of the same district.
| MDL | Actions pending |
|---|---|
| MDL No. 2738 IN RE: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation | 69,376 |
| MDL No. 2875 IN RE: Valsartan, Losartan, and Irbesartan Products Liability Litigation | 1,422 |
| MDL No. 2921 IN RE: Allergan Biocell Textured Breast Implant Products Liability Litigation | 1,370 |
| MDL No. 2243 IN RE: Fosamax (Alendronate Sodium) Products Liability Litigation (No. II) | 559 |
| MDL No. 3080 IN RE: Insulin Pricing Litigation | 516 |
| MDL No. 2973 IN RE: Elmiron (Pentosan Polysulfate Sodium) Products Liability Litigation | 184 |
| MDL No. 2904 IN RE: American Medical Collection Agency, Inc., Customer Data Security Breach Litigation | 42 |
| MDL No. 3180 IN RE: Dupixent (Dupilumab) Products Liability Litigation | 40 |
| MDL No. 3113 IN RE: Apple Inc. Smartphone Antitrust Litigation | 29 |
| MDL No. 3138 IN RE: Denosumab Patent Litigation | 4 |
| MDL No. 1663 IN RE: Insurance Brokerage Antitrust Litigation | 2 |
Source: jpml.uscourts.gov.
Method
Each figure is a count printed in the panel's monthly MDL Statistics Report, and a change is the difference between two printed counts; the full method.
Cite: Judicial Panel on Multidistrict Litigation, MDL Statistics Report - Distribution of Pending MDL Dockets by District, report date , the report's PDF; compiled by Repleader.
Source: JPML pending MDL report